Timing of Primary Surgery for Cleft Palate

NCT ID: NCT00993551

Last Updated: 2021-08-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

558 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-07-31

Study Completion Date

2021-03-26

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This trial is a randomised controlled trial with a parallel design taking place in centres across the UK, Scandinavia and Brazil.

650 infants with a diagnosis of isolated cleft palate who are considered medically fit for operation at 6 months, and who meet the inclusion criteria, will be included in the trial and randomised to receive either:

* Surgery at age 6 months, OR
* Surgery at age 12 months.

The main objective is to determine whether surgery for cleft palate, using a Sommerlad technique, at age 6 months, when compared to surgery using the same technique at age 12 months, improves velopharyngeal function at age 5 years. All infants will be followed up at age 12 months, 3 years and five years for the assessment of the primary outcomes( at age 5 years) and secondary outcomes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Infants will be followed up at age 12 months, 3 years and five years. At each visit the following will be assessed:

Age 12 months

* Speech development (canonical babbling)
* Audiological assessments
* Growth

Age 3 years

* Speech development
* Audiological assessments

Age 5 Years

* Speech development
* Audiological assessments
* Dentofacial development (Soft Tissue ANB and Maxillary arch constriction score using modified Huddart Bodenham scoring)

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cleft Palate

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

12 month surgery

Infants will receive primary surgery at age 12 months using Sommerlad technique

Group Type EXPERIMENTAL

primary surgery for cleft palate

Intervention Type PROCEDURE

Surgery completed using the Sommerlad technique

6 month surgery

Infants will receive primary surgery at age 6 months using Sommerlad technique.

Group Type EXPERIMENTAL

primary surgery for cleft palate

Intervention Type PROCEDURE

Surgery completed using the Sommerlad technique

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

primary surgery for cleft palate

Surgery completed using the Sommerlad technique

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Infants with isolated cleft palate
* Medically fit for operation at 6 months, corrected for gestational age
* Written informed proxy consent
* One parent/carer a native language speaker in the country of residence

Exclusion Criteria

* Consent not obtained
* b. Infants with syndromic cleft palate (except Van der Woude syndrome, which can be included if hearing is not affected) or severe developmental delay
* Congenital sensorineural hearing loss or middle ear anomalies;
* Variation in the anatomical presentation is such that the surgeon who will perform the procedure considers that one stage closure with the Sommerlad technique would be inappropriate;
* Submucous cleft palate (defined by the classical triad of signs, bifid, uvula, bony defect of the hard palate, muscular diastasis, as described by Jensen et al (1988).
* Where the language spoken at home is not the majority language in the country of residence.
Maximum Eligible Age

6 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Liverpool

OTHER

Sponsor Role collaborator

National Institute of Dental and Craniofacial Research (NIDCR)

NIH

Sponsor Role collaborator

University of Copenhagen

OTHER

Sponsor Role collaborator

Göteborg University

OTHER

Sponsor Role collaborator

Kevin Munro

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Kevin Munro

Professor of Audiology

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kevin J Munro

Role: PRINCIPAL_INVESTIGATOR

University of Manchester

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Sao Paulo

Bauru, , Brazil

Site Status

Århus Speech and Hearing Institute

Aarhus, , Denmark

Site Status

Copenhagen Cleft Palate Centre

Copenhagen, , Denmark

Site Status

Helse Bergen HF

Bergen, , Norway

Site Status

Oslo University Hospital

Oslo, , Norway

Site Status

Göteborg University

Gothenburg, , Sweden

Site Status

University of Linköping

Linköping, , Sweden

Site Status

Malmö University Hospital

Malmo, , Sweden

Site Status

Karolinska University Hospital

Stockholm, , Sweden

Site Status

Umeå University

Umeå, , Sweden

Site Status

Uppsala University

Uppsala, , Sweden

Site Status

Belfast Health and Social Care Trust

Belfast, , United Kingdom

Site Status

Birmingham Children's NHS Foundation Trust

Birmingham, , United Kingdom

Site Status

North Bristol NHS Foundation Trust

Bristol, , United Kingdom

Site Status

Edinburgh Hospital for Sick Children

Edinburgh, , United Kingdom

Site Status

NHS Greater Glasgow and Clyde

Glasgow, , United Kingdom

Site Status

Leeds University Hospitals NHS foundation Trust

Leeds, , United Kingdom

Site Status

Alder Hey Children's NHS Foundation Trust

Liverpool, , United Kingdom

Site Status

Manchester University NHS Foundation Trust

Manchester, , United Kingdom

Site Status

Newcastle University Hospitals NHs Foundation Trust

Newcastle, , United Kingdom

Site Status

Oxford University Hospitals NHS Trust

Oxford, , United Kingdom

Site Status

Salisbury District Hospital

Salisbury, , United Kingdom

Site Status

Abertawe Bro Morgannwg University Health Board

Swansea, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Brazil Denmark Norway Sweden United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Gamble C, Persson C, Willadsen E, Albery L, Soegaard Andersen H, Zattoni Antoneli M, Appelqvist M, Aukner R, Bodling P, Bowden M, Brunnegard K, Cairns G, Calladine S, Campbell L, Clayton-Smith J, Cooper R, Conroy E, El-Angbawi A, Kildegaard Emborg B, Enfalt Wikman J, Fitzpatrick B, Fukushiro AP, Guedes de Azevedo Bento Goncalves C, Havstam C, Hvistendahl AK, Jorgensen LD, Klinto K, Berntsen Kvinnsland M, Larham C, Lemvik J, Leturgie L, Liljerehn E, Lodge N, Lohmander A, McMahon S, Mehendale F, Miguel HC, Moe M, Nielsen JB, Nyberg J, Pedersen NH, Phippen G, Alvarez Piazentin-Penna SH, Patrick K, Pliskin L, Rigby L, Semb G, Southby L, Sporre M, Bjorkman Taleman AS, Tangstad J, Trindade IEK, Underwood I, van Eeden S, Westberg LR, Williamson PR, Paciello Yamashita R, Munro K, Walsh T, Shaw W; TOPS Study Group. Timing of Primary Surgery for Cleft Palate. N Engl J Med. 2023 Aug 31;389(9):795-807. doi: 10.1056/NEJMoa2215162.

Reference Type DERIVED
PMID: 37646677 (View on PubMed)

Willadsen E, Cooper R, Conroy E, Gamble C, Albery L, Andersen H, Appelqvist M, Bodling P, Bowden M, Brunnegard K, Enfalt J, van Eeden S, Goncalves C, Fukushiro A, Jorgensen L, Lemvik J, Leturgie L, Liljerehn E, Lodge N, McMahon S, Miguel H, Patrick K, Phippen G, Piazentin-Penna S, Southby L, Taleman AS, Tangstad J, Yamashita R, Shaw W, Munro K, Walsh T, Persson C. Inter-rater reliability in classification of canonical babbling status based on canonical babbling ratio in infants with isolated cleft palate randomised to Timing of Primary Surgery for Cleft Palate (TOPS). Clin Linguist Phon. 2023 Jan 2;37(1):77-98. doi: 10.1080/02699206.2021.2012259. Epub 2022 Jan 31.

Reference Type DERIVED
PMID: 35100923 (View on PubMed)

Conroy EJ, Cooper R, Shaw W, Persson C, Willadsen E, Munro KJ, Williamson PR, Semb G, Walsh T, Gamble C; TOPS trial management group. A randomised controlled trial comparing palate surgery at 6 months versus 12 months of age (the TOPS trial): a statistical analysis plan. Trials. 2021 Jan 4;22(1):5. doi: 10.1186/s13063-020-04886-y.

Reference Type DERIVED
PMID: 33397459 (View on PubMed)

Shaw W, Semb G, Lohmander A, Persson C, Willadsen E, Clayton-Smith J, Trindade IK, Munro KJ, Gamble C, Harman N, Conroy EJ, Weichart D, Williamson P. Timing Of Primary Surgery for cleft palate (TOPS): protocol for a randomised trial of palate surgery at 6 months versus 12 months of age. BMJ Open. 2019 Jul 11;9(7):e029780. doi: 10.1136/bmjopen-2019-029780.

Reference Type DERIVED
PMID: 31300507 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1U01DE018837-01A1

Identifier Type: NIH

Identifier Source: secondary_id

View Link

Sponsor Reference: 57201

Identifier Type: OTHER

Identifier Source: secondary_id

NIHR Portfolio Reference 30200

Identifier Type: OTHER

Identifier Source: secondary_id

09-017-E

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.